A case of atorvastatin combined toxic myopathy and inflammatory myositis

Journal of Clinical Rheumatology

Volumn 7, Issue 5, 2001, Pages 340-345

  Folzenlogen, Darcy ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Department of Medicine   (United States)

Author keywords

HMG CoA reductase inhibitors; Myopathy; Myositis; Statins

Indexed keywords

ANTINUCLEAR ANTIBODY; ATORVASTATIN; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MUSCLE ENZYME; PREDNISONE;

AGED; ARTICLE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MUSCLE BIOPSY; MYOPATHY; MYOSITIS; PRIORITY JOURNAL; SEROLOGY;

EID: 0034764889     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200110000-00019     Document Type: Article

References (25)

1. Current perspectives on statins
2. Long term clinical tolerance of lovastatin and simvastatin
3. HMG-CoA reductase inhibitors as lipid lowering agents: Five years experience with lovastatin, and an appraisal of simvastatin and pravastatin
4. Lovastatin and simvastatin-inhibitors of HMG-CoA reductase and cholesterol biosynthesis
5. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia
6. Drugs and toxins associated with myopathies
7. Lovastatin/gemfibrozil: A clinical, histochemical and ultrastructural study
8. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia
9. Case of the month: February 1999-54 year old man with severe muscle weakness
10. Drug interactions and statins
11. Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: The role of metabolism-monograph for physicians
12. Increased incidence of myositis in patients treated with high dose simvastatin
13. Myositis specific autoantibodies: Touchstones for understanding the inflammatory myopathies
14. Clinical serologic and immunogenetic factors in Polish patients with idiopathic inflammatory myopathies
15. Clinical features of inflammatory muscle disease
16. Myositis: Immunologic contributions to understanding cause, pathogenesis, and therapy
17. Anti-Ku antibodies in connective tissue disease, report of 3 cases
18. Ku antigen binds to Alu family of DNA
19. DNA dependent protein kinase (Ku protein-p350 complex) assembles on double stranded DNA
20. Enhancer 1 binding factor, a Ku related protein is a positive regulator of RNA polymerase I transcription initiation
21. Isolation and characterization of cDNA encoding 80kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantigens from patients with scleroderma/polymyositis overlap syndrome
22. Mechanism of interaction of Ku protein and DNA
23. Polymyositis associated with simvastatin
24. Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG Co a reductase inhibitors: A report of ten cases
25. Systemic immune reactions to HMG-CoA reductase inhibitors: Report of 4 cases and review of the literature